Furthermore, as a specific T-type calcium channel inhibitor, TTA-Q6 released from the nanomedicine prevents the tumor cells from uptaking extracellular calcium ions, therefore inducing intracellular calcium deficiency and endoplasmic reticulum (ER) stress, ultimately resulting in the translocation of CRT expression from ER onto plasma membrane23–28. This evidence concerns the gene CALR and neoplasm.